夏振源醫師發表論文與書籍

1. Hsia CY, Chiu JH, Lui WY. Elective interval laparoscopic management for periappendiceal abscess. Chung Hua I Hsueh Tsa Chin (Taipei) 1995;56:52-7. (sci)

2. Shen KH, Wu CW, Lo SS, Hsieh MC, Hsia CY, Chiang SC, Lui WY. Factors correlated with numbers of metastatic lymph nodes in gastric cancer. Am J Gastroenterol 999;94:104-8. (sci)

3. Hsia CY, Wu CW, Lui WY. Heterotopic pancreas: a difficult diagnosis. J Clin Gastroenterol 1999;28:144-7. (sci)

4. Lui WY, Chiu ST, Chiu JH, Loong CC, Chau GY, King KL, Hsia CY, Wu CW. Evaluation of a simplified staging system for prognosis of hepatocellular carcinoma. J Formos Med Assoc 1999;98:248-53. (sci)

5. Chen JH, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hsia CY, Wu CW. Surgical results in patients with hepatitis-B related hepatocellular carcinoma and positive epatitis B early antigen. World J Surg 2000;24:383-7. (sci)

6. Chau GY, Lui WY, Lui WY, Chang TJ, Kao HL, Wu LH, King KL, Loong CC, Hsia CY, Chi CW. Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Ann Surg 2000;231(4): 552-8. (sci)

7. Hsia CY, Lui WY, Chau GY, King KL, Loong CC, Wu CW. Perioperative safety and prognosis in hepatocellular carcinoma patients with impaired liver function. J Am Coll Surg 2000;190:574-9. (sci)

8. Tsai TJ, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hsia CY, Wu CW. Clinical significance of micrscopic tumor venous invasion in patients with respectable epatocellular carcinoma. Surgery 2000;127:603-8. (sci)

9. Lee CC, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hsia CY, Wu CW. Better post-resectional survival in female cirrhotic patients with hepatocellular carcinoma. Hepato-Gastroenerology 2000;47:446-9. (sci)

10. Chen TH, Tseng LM, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hsia CY, Wu CW. Clinicopathologic and prognostic differences between patients with hepatitis B and C related respectable hepatocellular carcinoma. J Formos Med Assoc 2001;100:443-8. (sci)

11. Lu CC, Chen CC, Hsia CY, Chiang JH, Tsay SH, Han HF, Chang FY, Lee SD. A progressive growing inflammatory pseudotumor of the liver. Journal of Chinese Medical Association 2001; 64:725-30. (sci)

12. Hsia CY, Chau GY, King KL, Loong CC, Lui WY, Wu CW. Factors for prolonged length of stay after elective hepatectomy for hepatocellular carcinoma. The surgeon's role in the managed care era. Hepatogastroenterology. 2003 May- Jun;50(51):798-804. (sci)

13. Li CH, Chau GY, Lui WY, Tsay SH, King KL, Hsia CY, Wu CW. Risk factors associated with intra-operative major blood loss in patients with hepatocellular carcinoma who underwent hepatic resection. Journal of Chinese Medical Association 2003; 66:669-75.

14. Kwok CM, Liu WY, Chau GY, King KL, Loong CC, Chau GY, Kwang WK, Hsia CY, Wu CW. Intrahepatic splenosis: Report of A case. Formos J Surg 2003:36:301-5.

15. Huo TI, Wu JC, Hsia CY, Chau GY, Lui WY, Huang YH, Lee PC, Chang FY, Lee SD. Hepatitis C virus infection is a risk factor for tumor recurrence after resection of small hepatocellular carcinomas. World J Surg. 2004 Aug;28(8):787- 91. (sci)

16. Chou YH, Chiou HJ, Tiu CM, Chiou SY, Hsia CY, Tsay SH. Splenic hamartoma: presentation on contrast-enhanced sonography. J Clin Ultrasound. 2004 Oct;32(8):425-8. (sci)

17. Hsu CW, Lui WY, Chau GY, King KL, Loong CC, Hsia CY*, Lee RC, Li AF, Wu CW. Clinical characteristics of patients undergoing surgical resection of benign liver tumors in Taiwan, an endemic area for hepatocellular carcinoma. J Formos Med Assoc. 2004 Nov;103(11):824-9. (sci)

18. Lee CC, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hsia CY, Wu CW. Risk factors associated with bile leakage after hepatic resection for hepatocellular carcinoma. Hepatogastroenterology. 2005 Jul-Aug;52(64):1168-71. (sci)

19. Liu C, Tsai HL, Loong CC, Hsia CY, Chin T, Wei C. ENDO-GIA staplers for side-to-side anastomosis of veins. Eur J Vasc Endovasc Surg. 2006 Nov;32(5):584-8. (sci)

20. Liu C, Tsai HL, Chin T, Loong CC, Hsia CY, Wei C. Clamping the supra-celiac aorta can effectively increase the success rate of orthotopic rat liver transplantation by increasing the tolerable time of the anhepatic phase. J Surg Res. 2006 Nov;136(1):116-9. (sci)

21. Hsia CY*, Huo TI, Chiang SY, Lu MF, Sun CL, Wu JC, Lee PC, Chi CW, Lui WY, Lee SD. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma. Eur J Surg Oncol. 2007 Mar;33(2):208-12. (sci)

22. Huo TI, Hsia CY*, Chu CJ, Huang YH, Lui WY, Wu JC, Lee PC, Chi CW, Lee SD. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance. J Surg Oncol. 2007 Jun 15;95(8):645-51. (sci)

23. Huang CS, Hsu WH, Hsia CY. Supradiaphragmatic ectopic liver: delayed traumatic hepatic hernia mimics pulmonary tumor. Thorac Cardiovasc Surg. 2007 Jun;55(4):277-8.（case report） (sci)

24. Liu C, Loong CC, Hsia CY, Tsai HL, Wei CF. "Modified side-to-side cavocaval anastomosis in selected cases of orthotopic liver transplantation". Surgery. 2007 Jul;142(1):123-4. (sci)（letter）

25. Huo TI, Lin HC, Hsia CY, Wu JC, Lee PC, Chi CW, Lee SD. The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: a prospective sequential survey. Am J Gastroenterol. 2007 Sep;102(9):1920-30. (sci)

26. Lin NC, Hsia CY*, Loong CC, Liu CS, Tsai HL, Lui WY, Wu CW. Liver Transplantation at a Small-volume Procedure Center---Preliminary Results from Taipei Veterans General Hospital. J Chin Med Assoc. 2008 Apr;71(4):186-90.

27. Hsia CY;肝癌患者接受肝臟移植後腫瘤復發的探討.臨床醫學月刊 2008;61:450-3

28. Liu C, Loong CC, Hsia CY, Tsou MY, Tsai HL, Wei CF. Venoplasty of hepatic venous outflow with a venous patch in domino liver transplantation. Liver Transpl. 2008 Sep;14(9):1378-9. (sci)

29. Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD. The MELD-Na is an independent short- and long-term prognostic predictor for  epatocellular carcinoma: a prospective survey. Dig Liver Dis. 2008 Nov;40(11):882-9. (sci)

30. Liu C, Hsia CY, Loong CC, Perng CK, Huang CH, Tsai HL, Tsou MY, Wei C. A technique of diamond-shape venoplasty to reconstruct the hepatic venous outflow in living donor liver transplantation for a case of Budd-Chiari syndrome. Pediatr Transplant. 2009 Feb;13(1):35-8. (sci)

31. Huo TI, Huang YH, Hsia CY, Su CW, Lin HC, Hsu CY, Lee PC, Lui WY, Loong CC, Chiang JH, Chiou YY, Lee SD. Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection? Liver Int. 2009 May;29(5):767-73. (sci)

32. Hung HH, Chen TS, Tseng HS, Hsia CY, Liu CS, Lin HC, Loong CC.Percutaneous transhepatic cholangiography and drainage is an effective rescue therapy for biliary complications in liver transplant recipients who fail endoscopic retrograde cholangiopancreatography. J Chin Med Assoc. 2009 Aug;72(8):395-401.

33. Huo TI, Hsia CY*, Huang YH, Lin HC, Lee PC, Lui WY, Chiang JH, Chiou YY, Loong CC, Lee SD.Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems. J Clin Gastroenterol. 2009 Sep;43(8):773-81.

34. Liu C, Loong CC, Hsia CY, Peng CK, Tsai HL, Tsou MY, Wei C.Duct-to-duct biliary reconstruction in selected cases in pediatric living-donor left-lobe liver transplantation. Pediatr Transplant. 2009 Sep;13(6):693-6. Epub 2008 Nov 26.

35. Kuo WT, Hsia CY*, Loong CC, Liu CS, Tsai HL, Tseng HS, Lee RC, Tsou MY, Wu CW, Lui WY.Outcome of foreign residents undergoing deceased donor liver transplantation in China: a single-center experience in Taiwan. Liver Transpl. 2009 Nov;15(11):1579-85.

36. Liu C, Loong CC, Hsia CY, Tsai HL, Wei CF. ENDO-GIA staplers for side-to-side anastomosis of veins.Liver Transpl. 2009 Nov;15(11):1655.（letter）

37. Liu C, Loong CC, Hsia CY, Tsou MY, Tsai HL, Wei C. Retrograde arterial flush of the liver graft in living donor liver transplantation. J Invest Surg. 2009 Nov-Dec;22(6):406-12.

38. Huo TI, Hsu CY, Huang YH, Hsia CY, Lin HC, Lee PC, Loong CC, Chiang JH, Chiou YY, Lee SD.Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma. Liver Int. 2010 Feb;30(2):198-207. Epub 2009 Oct 22.

39. Lin NC, Liu CS, Chang CJ, Loong CC, Hsia CY, Tsai HL.Changes in mitochondrial respiratory enzyme activity after ischemia-reperfusion injury in living-donor liver transplantation. Transplant Proc. 2010 Apr;42(3):721-4.

40. Liu C, Niu DM, Loong CC, Hsia CY, Tsou MY, Tsai HL, Wei C.Domino liver graft from a patient with homozygous familial hypercholesterolemia. Pediatr Transplant. 2010 May;14(3):E30-3. Epub 2009 Mar 10.

41. Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Lee PC, Loong CC, Chiang JH, Huo TI, Lee SD. Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic models. Cancer. 2010 Jun 15;116(12):3006-14.

42. Lin YH, Lee RC, Hsia CY, Chen HC, Chiang JH, Tseng HS, Chang CY. Right hepatic artery pseudoaneurysm ruptured into the gallbladder demonstrated by magnetic resonance angiography. J Chin Med Assoc. 2010 Jun;73(6):331-3.（case report）

43. Hsu CY, Huang YH, Hsia CY, Su CW, Lin HC, Loong CC, Chiou YY, Chiang JH, Lee PC, Huo TI, Lee SD.A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System. J Hepatol. 2010 Jul;53(1):108-17. Epub 2010 Mar 31.

44. Liu C, Niu DM, Hsia CY, Loong CC, Lin NC, Tsai HL, Tsou MY, Chin T.Living donor liver transplantation using a graft from a donor with Dubin-Johnson syndrome. Pediatr Transplant. 2010 Sep 1. [Epub ahead of print]

45. Liu C, Lee RC, Loong CC, Hsia CY, Yeh YC, Chiou SY. Increasing donor body weight to prevent small-for-size syndrome in living donor liver transplantation. World J Surg. 2010 Oct;34(10):2401-8.

46. Hung HH, Chiou YY, Hsia CY, Su CW, Chou YH, Chiang JH, Kao WY, Huo TI, Huang YH, Su YH, Lin HC, Lee SD, Wu JC. Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas. Clin Gastroenterol Hepatol. 2011 Jan;9(1):79-86. Epub 2010 Sep 8.

48.Chang WT, Lin NC, Hsia CY, Liu CS, Tsai HL, Loong CC. Liver transplantation for a renal transplantation recipient with secondary sclerosing cholangitis by choledochoduodenal fistula. Asian J Surg. 2012 Jan;35(1):49-52.

49.Su CW, Lei HJ, Chau GY, Hung HH, Wu JC, Hsia CY, Lui WY, Su YH, Wu CW, Lee SD. The effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: a propensity score matching analysis. Arch Surg. 2012 Feb;147(2):137-44.

50.Liu C, Niu DM, Hsia CY, Loong CC, Lin NC, Tsai HL, Tsou MY, Chin T. Living donor liver transplantation using a graft from a donor with Dubin-Johnson syndrome. Pediatr Transplant. 2012 Feb;16(1):E25-9.

51.Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Pai JT, Loong CC, Chiou YY, Lee RC,Lee FY, Huo TI, Lee SD. Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis. Ann Surg Oncol. 2012 Mar;19(3):842-9.

52.Liu C, Loong CC, Hsia CY, Wang SC, Yeh YC, Lin NC, Tsai HL, Tsou MY. Retrograde arterial flush of the liver graft in living donor liver transplantation may ameliorate post-transplantational cholestasis—prospective randomized study. Clin Transplant. 2012 Mar-Apr;26(2):305-13.

53.Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Chiou YY, Lee RC, Lee FY, Huo TI, Lee SD. Differential prognostic impact of renal insufficiency on patients with hepatocellular carcinoma: a propensity score analysis and staging strategy. J Gastroenterol Hepatol. 2012 Apr;27(4):690-9.

54.Chen CY, Wang JB, Lin NC, Lee JT, Tsai HL, Chin T, Loong CC, Hsia CY, Liu C. Three liver grafts from a deceased whole liver. Med Hypotheses. 2012 May;78(5):668-71.

55.Hsu CY, Lee YH, Hsia CY, Huang YH, Su CW, Lin HC, Lee RC, Chiou YY, Lee FY, Huo TI. Performance status in patients with hepatocellular carcinoma: Determinants, prognostic impact and ability to improve the BCLC system. Hepatology. 2013 Jan;57(1):112-9.

56.Lee YH, Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Chiou YY, Huo TI. A prognostic model for patients with hepatocellular carcinoma within the Milan criteria undergoing non-transplant therapies, based on 1106 patients. Aliment Pharmacol Ther. 2012 Sep;36(6):551-9.

57.Lee YH, Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Loong CC, Chiou YY, Huo TI. Defining the severity of liver dysfunction in patients with hepatocellular carcinoma by the model for end-stage liver disease-derived systems. Dig Liver Dis. 2012 Oct;44(10):868-74.

58.Chang WT, Kao WY, Chau GY, Su CW, Lei HJ, Wu JC, Hsia CY, Lui WY, King KL, Lee SD. Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: Extending the Indication for resection? Surgery. 2012 Nov;152(5):809-20.

59.Lin NC, Niu DM, Loong CC, Hsia CY, Tsai HL, Yeh YC, Tsou MY, Liu CS. Liver transplantation for a patient with homocystinuria. Pediatr Transplant. 2012 Nov;16(7):E311-E314.

60. Hung HH, Lei HJ, Chau GY, Su CW, Hsia CY, Kao WY, Lui WY, Wu WC, Lin HC, Wu JC. Milan Criteria, Multi-nodularity, and Microvascular Invasion Predict the Recurrence Patterns of Hepatocellular Carcinoma After Resection. J Gastrointest Surg. 2013 Apr;17(4):702-11.

61.Lee YH, Hsu CY, Huang YH, Hsia CY, Chiou YY, Su CW, Lin HC, Huo TI. Vascular Invasion in Hepatocellular Carcinoma: Prevalence, Determinants and Prognostic Impact. J Clin Gastroenterol. 2014 Sep;48(8):734-41.

62. Chen CY, Tseng HS, Lin NC, Wang JB, Tsai HL, Loong CC, Hsia CY, Liu C. A bidirectional approach for portal vein stent placement in a child with completeportal vein occlusion after living donor liver transplantation. Pediatr Transplant. 2013 Sep;17(6):E137-40.

63. Ling CH, Chau GY, Hsia CY, King KL. Significance of incorporation of model for end-stage liver disease score with TNM staging in patients with hepatocellular carcinoma undergoing hepatic resection. Hepatogastroenterology. 2013 Jul-Aug;60(125):1142-7.

64. Hsu CC, Wang CH, Wu LC, Hsia CY, Chi CW, Yin PH, Chang CJ, Sung MT, Wei YH, Lu SH, Lee HC. Mitochondrial dysfunction represses HIF-1α protein synthesis through AMPK activation in human hepatoma HepG2 cells. Biochim Biophys Acta. 2013 Oct;1830(10):4743-51.

65. Lee YH, Hsia CY, Hsu CY, Huang YH, Lin HC, Huo TI. Total tumor volume is a better marker of tumor burden in hepatocellular carcinoma defined by the Milan criteria.World J Surg. 2013 Jun;37(6):1348-55.

66. Hsu CY, Lee YH, Hsia CY, Huang YH, Su CW, Lin HC, Chiou YY, Lee FY, Huo TI. Performance status enhances the selection of treatment for patients with hepatocellular carcinoma within the milan criteria. Ann Surg Oncol. 2013 Jun;20(6):2035-42.

67. Hung HH, Lei HJ, Chau GY, Su CW, Hsia CY, Kao WY, Lui WY, Wu WC, Lin HC, Wu JC. Milan criteria, multi-nodularity, and microvascular invasion predict the recurrence patterns of hepatocellular carcinoma after resection. J Gastrointest Surg. 2013 Apr;17(4):702-11.

68. Lee YH, Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Lee RC, Chiou YY, Huo TI. Hepatocellular carcinoma in uremic patients: is there evidence for an increased risk of mortality? J Gastroenterol Hepatol. 2013 Feb;28(2):348-56.

69. Lee YH, Hsu CY, Huang YH, Su CW, Lin HC, Hsia CY*, Huo TI. α-fetoprotein-to-total tumor volume ratio predicts post-operative tumor recurrence in hepatocellular carcinoma. J Gastrointest Surg. 2013 Apr;17(4):730-8.

70. Hsu CY, Lee YH, Hsia CY, Huang YH, Su CW, Lin HC, Lee RC, Chiou YY, Lee FY, Huo TI. Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system. Hepatology. 2013 Jan;57(1):112-9.

71. Liu PH, Hsu CY, Lee YH, Hsia CY, Huang YH, Su CW, Chiou YY, Lin HC, Huo TI. Uncompromised treatment efficacy in elderly patients with hepatocellular carcinoma: a propensity score analysis. Medicine (Baltimore). 2014 Dec;93(28):e264.

72. Lee YH, Hsu CY, Huang YH, Hsia CY, Chiou YY, Su CW, Lin HC, Huo TI. Vascular invasion in hepatocellular carcinoma: prevalence, determinants and prognostic impact. J Clin Gastroenterol. 2014 Sep;48(8):734-41.

73. Liu PH, Lee YH, Hsu CY, Hsia CY, Huang YH, Chiou YY, Lin HC, Huo TI. Surgical resection is better than transarterial chemoembolization for hepatocellular carcinoma beyond Milan criteria independent of performance status. J Gastrointest Surg. 2014 Sep;18(9):1623-31.

74. Liu PH, Lee YH, Hsia CY, Hsu CY, Huang YH, Chiou YY, Lin HC, Huo TI. Surgical resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis. Ann Surg Oncol. 2014 Jun;21(6):1825-33.

75. Lee YH, Hsu CY, Chu CW, Liu PH, Hsia CY, Huang YH, Su CW, Chiou YY, Lin HC, Huo TI. A new Child-Turcotte-Pugh class 0 for patients with hepatocellular carcinoma: determinants, prognostic impact and ability to improve the current staging systems. PLoS One. 2014 Jun 6;9(6):e99115.

76. Hsu CY, Lee YH, Liu PH, Hsia CY, Huang YH, Lin HC, Chiou YY, Lee FY, Huo TI. Decrypting cryptogenic hepatocellular carcinoma: clinical manifestations, prognostic factors and long-term survival by propensity score model. PLoS One. 2014 Feb 24;9(2):e89373.

77. Chen CY, Liu CJ, Feng JY, Loong CC, Liu C, Hsia CY, Hu LY, Lin NC, Hu YW, Yeh CM, Chen TJ, Yang CC. Incidence and Risk Factors for Tuberculosis After Liver Transplantation in an Endemic Area: A Nationwide Population-Based Matched Cohort Study. Am J Transplant. 2015 Aug ;15(8):2180-7.

78. Hsu CY, Liu PH, Lee YH, Hsia CY, Huang YH, Chiou YY, Tsai YJ, Nagaria TS, Huo TI. Aggressive therapeutic strategies improve the survival of hepatocellular carcinoma patients with performance status 1 or 2: a propensity score analysis. Ann Surg Oncol. 2015 Apr;22(4):1324-31.

79. Liu PH, Hsia CY, Lee YH, Hsu CY, Huang YH, Su CW, Lee RC, Lin HC, Huo TI. Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma. J Surg Oncol. 2015 Mar 15;111(4):404-9.

80. Liu PH, Hsu CY, Hsia CY, Lee YH, Huang YH, Chiou YY, Lin HC, Huo TI. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma .2 cm in a Propensity Score Model. Ann Surg. 2015 Mar 13. [Epub ahead of print].

81. Lee YH, Hsu CY, Chu CW, Liu PH, Hsia CY, Huang YH, Su CW, Chiou YY, Lin HC, Huo TI. Radiofrequency ablation is better than surgical resection in patients with hepatocellular carcinoma within the Milan criteria and preserved liver function: a retrospective study using propensity score analyses. J Clin Gastroenterol. 2015 Mar;49(3):242-9.

82. Hsu CY, Liu PH, Lee YH, Hsia CY, Huang YH, Tsai YJ, Nagaria TS, Lin HC, Huo TI. Active Treatments Prolong the Survival in Patients With Hepatocellular Carcinoma and Performance Status 3 or 4: A Propensity Score Analysis. J Clin Gastroenterol. 2015 November/December. 49(10):878–84.

83. Hsu CY, Liu PH, Lee YH, Hsia CY, Huang YH, Lin HC, Chiou YY, Lee FY, Huo TI. Using serum α-fetoprotein for prognostic prediction in patients with hepatocellular carcinoma: what is the most optimal cutoff? PLoS One. 2015 Mar 4;10(3):e0118825.

84. Su CW, Chau GY, Hung HH, Yeh YC, Lei HJ, Hsia CY, Lai CR, Lin HC, Wu JC. Impact of Steatosis on Prognosis of Patients with Early-Stage Hepatocellular Carcinoma After Hepatic Resection. Ann Surg Oncol. 2015 Jul; 22(7):2253-61.

85. Sung MT, Hsu HT, Lee CC, Lee HC, Kuo YJ, Hua K, Hsia CY*, Chi CW. Kruppel-like factor 4 modulates the migration and invasion of hepatoma cells by suppressing TIMP-1 and TIMP-2. Oncol Rep. 2015 Jul;34(1):439-46.

86. Liu PH, Hsu CY, Hsia CY, Lee YH, Su CW, Huang YH, Lee FY, Lin HC, Huo TI. Prognosis of Hepatocellular Carcinoma: Assessment of Eleven Staging Systems. J Hepatol. 2015 Nov 6. pii: S0168-8278(15)00730-8.

87. Liu PH, Hsu CY, Lee YH, Su CW, Hsia CY, Huang YH, Chiou YY, Lin HC, Huo TI. Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral Etiology. Medicine (Baltimore). 2015 Oct;94(41):e1772.

88. Hsu CY1, Liu PH, Lee YH, Hsia CY, Huang YH, Chiou YY, Lin HC, Huo TI. Hepatocellular Carcinoma Patients With Performance Status 1 Deserve New Classification and Treatment Algorithm in the BCLC System. Medicine (Baltimore). 2015 Jul;94(29):e1223.

89. Hsu CC, Wu LC, Hsia CY, Yin PH, Chi CW, Yeh TS, Lee HC. Energy metabolism determines the sensitivity of human hepatocellular carcinoma cells to mitochondrial inhibitors and biguanide drugs. Oncol Rep. 2015 Sep;34(3):1620

90. Liu PH, Su CW, Hsu CY, Hsia CY, Lee YH, Huang YH, Lee RC, Lin HC, Huo TI. Solitary Large Hepatocellular Carcinoma: Staging and Treatment Strategy. PLoS One. 2016 May 13;11(5):e0155588. doi: 10.1371/journal.pone.0155588. eCollection 2016.

91. Chen HC, Hsu HT, Weng JW, Chang YF, Hsia CY, Lee HC, Chi CW. Combined effect of honokiol and rosiglitazone on cell growth inhibition through enhanced G0/G1 phase arrest in hepatoma cells. J Chin Med Assoc. 2016 Apr 16. pii: S1726-4901(16)30018-1. doi: 10.1016/j.jcma.2016.03.003. [Epub ahead of print].

92. Hsu CY, Liu PH, Hsia CY, Lee YH, Juboori AA, Lee RC, Lin HC, Huo TI. Nomogram of the Barcelona Clinic Liver Cancer System for Individual Prognostic Prediction in Hepatocellular Carcinoma. Liver Int. 2016 Mar 12. doi: 10.1111/liv.13114. [Epub ahead of print].

93. Liu PH, Hsu CY, Hsia CY, Lee YH, Su CW, Huang YH, Lee FY, Lin HC, Huo TI. Prognosis of hepatocellular carcinoma: Assessment of eleven staging systems. J Hepatol. 2016 Mar;64(3):601-8. doi: 10.1016/j.jhep.2015.10.029. Epub 2015 Nov 11.

94. Liu PH, Hsu CY, Lee YH, Hsia CY, Huang YH, Su CW, Chiou YY, Lin HC, Huo TI. When to Perform Surgical Resection or Radiofrequency Ablation for Early Hepatocellular Carcinoma?: A Nomogram-guided Treatment Strategy. Medicine (Baltimore). 2015 Oct;94(43):e1808. doi: 10.1097/MD.0000000000001808.

95. Hsu CY, Liu PH, Hsia CY, Lee YH, Nagaria TS, Lee RC, Lin HC, Huo TI. Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram Study. Ann Surg Oncol. 2016 Mar; 23(3):994-1002. doi: 10.1245/s10434-015-4929-x. Epub 2015 Oct 20.

96. Liu PH, Hsu CY, Hsia CY, Lee YH, Chiou YY, Huang YH, Lee FY, Lin HC, Hou MC, Huo TI. ALBI and PALBI Grade Predict Survival for HCC across Treatment Modalities and BCLC Stages in the MELD Era. J Gastroenterol Hepatol. 2016 Oct 3. doi: 10.1111/jgh.13608. [Epub ahead of print]

97. Chen CY, Liu C, Lin NC, Tsai HL, Loong CC, Hsia CY. Exchange of Partial Liver Transplantation Between Children with Different Non-Cirrhotic Metabolic Liver Diseases: How Do We Arrive There? Ann Transplant. 2016 Aug 23;21:525-30.

98. Hsu HT, Sung MT, Lee CC, Kuo YJ, Chi CW, Lee HC, Hsia CY*. Peroxisome Proliferator-Activated Receptor γ Expression Is Inversely Associated with Macroscopic Vascular Invasion in Human Hepatocellular Carcinoma. Int J Mol Sci. 2016 Jul 29;17(8). pii: E1226. doi: 10.3390/ijms17081226.

99. Liu PH, Hsu CY, Hsia CY, Lee YH, Huang YH, Su CW, Lee FY, Lin HC, Huo TI. Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patients. Eur J Cancer. 2016 Aug;63:25-33. doi: 10.1016/j.ejca.2016.04.023.

100. Chen HC, Hsu HT, Weng JW, Chang YF, Hsia CY, Lee HC, Chi CW. Combined effect of honokiol and rosiglitazone on cell growth inhibition through enhanced G0/G1 phase arrest in hepatoma cells. J Chin Med Assoc. 2016 Aug;79(8):415-21. doi: 10.1016/j.jcma.2016.03.003.

101. Liu PH, Hsu CY, Hsia CY, Lee YH, Huang YH, Chiou YY, Lin HC, Huo TI. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma . 2 cm in a Propensity Score Model. Ann Surg. 2016 Mar;263(3):538-45. doi: 10.1097/SLA.0000000000001178. Erratum in: Ann Surg. 2016 May;263(5):e77.

102. Liu PH, Hsu CY, Hsia CY, Lee YH, Chiou YY, Huang YH, Lee FY, Lin HC, Hou MC, Huo TI. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era. J Gastroenterol Hepatol. 2017 Apr;32(4):879-886. doi: 10.1111/jgh.13608.

103. Chang ME, Lei HJ, Chen MH, Yeh YC, Li CP, Hung YP, Hsia CY, Liu CA, Chau GY, Chao Y. Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral center. J Chin Med Assoc. 2017 Mar;80(3):140-146. doi: 10.1016/j.jcma.2016.09.010. Epub 2017 Feb 4.

104. Su YW, Liu PH, Hsu CY, Lee YH, Hsia CY, Ho SY, Hou MC, Chen HS, Huo TI. Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective. PLoS One. 2017 Mar 23;12(3):e0174333. doi: 10.1371/journal.pone.0174333. eCollection 2017.

105. Ho SY, Liu PH, Hsu CY, Hsia CY, Lee YH, Lee RC, Huang YH, Lee FY, Hou MC, Tsai YJ, Huo TI. Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. PLoS One. 2017 Jul 3;12(7):e0180408. doi: 10.1371/journal.pone.0180408. eCollection 2017.

106. Hsu CY, Liu PH, Hsia CY, Lee YH, Nagaria TS, Lee RC, Ho SY, Hou MC, Huo TI. A New Treatment-integrated Prognostic Nomogram of the Barcelona Clinic Liver Cancer System for Hepatocellular Carcinoma. Sci Rep. 2017 Aug 11;7(1):7914. doi: 10.1038/s41598-017-08382-3.

107. Hsu CY, Liu PH, Ho SY, Hsia CY, Kudaravalli P, Lee YH, Chiou YY, Tsai YJ, Huang YH, Huo TI. Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma. BMC Cancer. 2018 Mar 14;18(1):289. doi: 10.1186/s12885-018-4202-3.

108. Ho SY, Liu PH, Hsu CY, Hsia CY, Su CW, Lee YH, Huang YH, Lee FY, Hou MC, Huo TI. Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection. Sci Rep. 2018 Mar 19;8(1):4773. doi: 10.1038/s41598-018-22923-4.

109. Ho SY, Liu PH, Hsu CY, Hsia CY, Su CW, He YJ, Lee YH, Huang YH, Hou MC, Huo TI. Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma. Sci Rep. 2018 Oct 10;8(1):15074. doi: 10.1038/s41598-018-33536-2.

110. Ho SY, Hsu CY, Liu PH, Hsia CY, Su CW, Huang YH, Hou MC, Huo TI. Albumin-bilirubin (ALBI) grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma. Eur J Surg Oncol. 2019 May;45(5):776-781. doi: 10.1016/j.ejso.2018.10.541. Epub 2018 Nov 1.

111. Ho SY, Liu PH, Hsu CY, Hsia CY, Su CW, Huang YH, Lei HJ, He YJ, Hou MC, Huo TI. An Albumin-Bilirubin (ALBI) Grade-based Prognostic Model For Patients With Hepatocellular Carcinoma Within Milan Criteria. Am J Clin Oncol. 2019 Sep;42(9):698-704. doi: 10.1097/COC.0000000000000581.

112. Ho SY, Hsu CY, Liu PH, Hsia CY, Lei HJ, Huang YH, Ko CC, Su CW, Lee RC, Hou MC, Huo TI. Albumin-bilirubin grade-based nomogram of the BCLC system for personalized prognostic prediction in hepatocellular carcinoma. Liver Int. 2019 Sep 10. doi: 10.1111/liv.14249. [Epub ahead of print]

113. Kuo PC, Chau IY, Li AF, Chauc YP, Hsia CY, Chau GY. Clusterin expression in non-tumor tissue in patients with resectable hepatocellular carcinoma related with post-resectional survival. J Chin Med Assoc. 2019 Sep 17. doi: 10.1097/JCMA.0000000000000195. [Epub ahead of print]

114. Ho SY, Liu PH, Hsu CY, Hsia CY, Huang YH, Su CW, Lei HJ, Lee RC, Hou MC, Huo TI. A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria. Dig Dis Sci. 2019 Oct 28. doi: 10.1007/s10620-019-05813-1. [Epub ahead of print]

115. Wu SH, Loong CC, Chu CJ, Su CW, Lin CC, Hsia CY, Liu C, Lee SD, Wang YJ, Lee FY, Lin NC, Chen CY, Huang YH, Hou MC. Highly effective treatment response and well tolerability by all oral direct acting antivirals for chronic hepatitis C patients post organ transplantation. J Chin Med Assoc. 2019 Nov 15. doi: 10.1097/JCMA.0000000000000222. [Epub ahead of print]

116. Kuo PC, Chau IY, Li AF, Chau YP, Hsia CY, Chau GY. Clusterin expression in nontumor tissue in patients with resectable hepatocellular carcinoma related with postresectional survival. J Chin Med Assoc. 2019 Dec;82(12):929-934. doi: 10.1097/JCMA.0000000000000195.